Relentlessly chasing cures through groundbreaking science
AviadoBio is a clinical-stage gene therapy company building on research from King's College London and UK Dementia Research Institute to develop potentially one-time treatments for neurodegenerative diseases. Uses engineered AAV vectors and proprietary vMiX RNA silencing. Lead program AVB-101 targets Frontotemporal Dementia caused by GRN mutations.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountApr 2025
Dec 2021
Dec 2021
Create a free account to see which investors have funded this company.
Create Free Account
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
